Caliper's Q3 Revenues Rise 24 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Caliper Life Sciences today reported that its third-quarter revenues increased 24 percent year over year, or 16 percent organically, with strong growth for its LabChip, imaging, and research products.

The Hopkinton, Mass.-based firm brought in total revenues of $36.9 million for the three-month period ended Sept. 30, compared to $29.7 million for the third quarter of 2010. It beat the Wall Street consensus estimate of $35.6 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.